However, another study found that in breast cancer, IL-17 significantly induced MDSCs differentiation, inhibited their proliferation, and triggered apoptosis via activating Stat3, although low IL-17 inhibited the activation of Stat3, leading to increase formation of MDSCs (47). This evidence concerns the gene IL17A and breast carcinoma.